Oregon 2025 Regular Session

Oregon House Bill HB2117

Introduced
1/13/25  

Caption

Relating to tax treatment of research expenditures; prescribing an effective date.

Impact

The proposed changes under HB 2117 would influence Oregon's tax structure significantly. By allowing research expenditures to be fully deducted in the year incurred and reinstating a robust tax credit for corporate research activities, the legislation aims to incentivize businesses to invest more in research and development. This could lead to increased economic activity in the state as businesses could potentially expand their operations and hire more employees, thereby boosting local employment rates. The Act applies to tax years beginning on or after January 1, 2025, and seeks to facilitate a more favorable environment for innovation in Oregon's corporate landscape.

Summary

House Bill 2117 is designed to reintroduce a tax credit aimed at fostering research and development activities within Oregon. This Act restores the corporate excise tax credit for qualified research activities, allowing companies to benefit from an increased maximum deduction. One of the key features of this legislation is that it permits the refundability and transferability of such credits, meaning that if a business has more credits than it can use in a given tax year, it can either receive a refund or transfer those credits to another taxpayer. Additionally, businesses are given the option to fully deduct their research and development expenditures in the year they are incurred rather than having to amortize them over several years, which can enhance their immediate cash flow and investment capabilities.

Sentiment

The sentiment surrounding HB 2117 appears generally positive, with support predominantly from business associations and industry leaders who assert that the measure is vital for stimulating economic growth through enhanced research capabilities. They argue it will help Oregon companies compete more effectively on a national and global scale. Conversely, some skepticism exists regarding the impact of expanded tax credits and whether it will substantively increase research investments from businesses, with critics urging for a careful examination of the long-term effects of such financial incentives on state revenues.

Contention

A notable point of contention regarding HB 2117 rests in the balance of providing tax incentives versus ensuring sufficient revenue for state needs. While proponents highlight the potential for job creation and economic stimulation through increased research activity, opponents caution that extensive tax credits could lead to future budget shortfalls, potentially hindering the state's ability to fund other essential services. The discussions around the bill indicate a need for careful consideration of how best to stimulate research and development without compromising the fiscal health of the state.

Companion Bills

No companion bills found.

Similar Bills

HI SB1204

Relating To The University Of Hawaii.

CA AB1103

Controlled substances: research.

AZ SB1722

Civil liability; fraudulent scientific research

IA HSB58

A bill for an act providing for the ethical use of research animals.

CA AB1338

Metal shredding facilities: regulations.

CA SB829

California Institute for Scientific Research: CalRx Initiative: vaccines.

NJ S4110

Requires New Jersey Commission on Science, Innovation, and Technology to establish matching grant program for public research universities that receive certain federal research grants; appropriates $5 million.

HI HB1257

Relating To Energy.